Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

The new gel for hair loss is safe, effective, and reduces side effects.

Pulsed electric field treatment may help the immune system fight liver tumors.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Intralesional triamcinolone is more effective than topical betamethasone for treating localized alopecia areata.

Analog 23 is a promising compound for prostate cancer treatment.

Cyproterone acetate reduced hair growth in most hirsute females and made hair softer, thinner, and lighter.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

The drug combination was safe and showed promise in treating advanced tumors.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

The new delivery method for dutasteride is more effective and has fewer side effects.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.